Genscript Biotech Co. (OTCMKTS:GNNSF) Sees Large Decline in Short Interest

Genscript Biotech Co. (OTCMKTS:GNNSF) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 549,600 shares, a decrease of 70.6% from the January 31st total of 1,867,800 shares. Based on an average daily volume of 200 shares, the days-to-cover ratio is presently 2,748.0 days.

Genscript Biotech Price Performance

Shares of GNNSF remained flat at C$1.90 during mid-day trading on Friday. Genscript Biotech has a 52 week low of C$1.05 and a 52 week high of C$2.05. The firm has a 50-day moving average of C$1.40 and a 200 day moving average of C$1.41.

About Genscript Biotech

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.